Effect of Heat on Chemotherapy for Peritoneal Tumors
Author Information
Author(s): G. Los, M.J.H. van Vugt, H.M. Pinedo
Primary Institution: The Netherlands Cancer Institute
Hypothesis
Does combining hyperthermia with intraperitoneal chemotherapy improve treatment outcomes for peritoneal tumors?
Conclusion
Combining hyperthermia with intraperitoneal chemotherapy significantly increases tumor growth delay and platinum concentrations in peritoneal tumors.
Supporting Evidence
- Hyperthermia increased the maximum tolerated dose of cisplatin by 33.3%.
- Platinum concentrations in tumors were significantly higher after hyperthermic treatment.
- Intraperitoneal chemotherapy combined with hyperthermia led to a tumor growth delay of over 40 days.
Takeaway
Heating the body while giving cancer medicine helps the medicine work better against tumors in the belly.
Methodology
Rats with peritoneal tumors were treated with cisplatin or carboplatin combined with regional hyperthermia, and tumor growth delay and platinum concentrations were measured.
Limitations
The study was conducted on rats, which may not fully represent human responses.
Participant Demographics
Male WAG/Rij rats, 8-12 weeks old, weighing 250-300 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website